Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Toradol patent to expire in May 1997 under federal appellate ruling.

Executive Summary

ROCHE TORADOL PATENT EXPIRES IN MAY 1997 UNDER APPEALS COURT RULING that will not allow Roche to add Waxman/Hatch time to the 20-year from filing patent term allowed by the General Agreement on Tariffs & Trade. Roche had claimed an expiration date of July 1998 in the case before the D.C. federal appeals court. Sales of the non-narcotic analgesic were $81.1 mil. from February to April 1994, the last reported quarter before Syntex was acquired by Roche.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028005

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel